Prabhudas Lilladher's research report on Laxmi Organic Industries
LXCHEM reported Q2FY26 revenue of Rs6.9bn, down 9.3% YoY but up 1% QoQ. The Essential Chemicals segment, contributing 74% of total revenue, declined 5% YoY. EBITDAM for the segment stood at 1.9% declined by 320bps YoY, impacted by falling prices of key raw material acetic acid, which compressed spreads in ethyl acetate (constitutes 80–85% of essentials basket). The Specialty Chemicals segment posted a 20% YoY revenue decline, impacted by the phase-out of a product contributing ~10% of the portfolio and the deferment of certain product deliveries to H2FY26. A replacement product for the phased-out product is expected to launch by Q4FY26, implying continued pressure on specialty revenues in Q3FY26. The Fluorochemicals segment remains in its ramp-up phase, with management guiding for 40–60% of its Rs2 bn peak revenue potential to be achieved in FY26. On the demand side, the Agrochemicals segment remains subdued, while sub-segments such as pharmaceuticals, printing & packaging, and colors & pigments continue to show stable trends.
Outlook
With ethyl acetate spreads likely to remain under pressure in the near term, we maintain a cautious view on the stock and retain our Reduce rating. The stock currently trades at 29x Sep’27E EPS. Using SOTPbased valuation, we arrive at a target price of Rs 192.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
